| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NOC | Common Stock | Options Exercise | $0 | +685 | +128% | $0.000000 | 1,222 | 18 Feb 2025 | Direct | |
| transaction | NOC | Common Stock | Tax liability | $97,099 | -220 | -18% | $441.36 | 1,002 | 18 Feb 2025 | Direct | |
| transaction | NOC | Common Stock | Options Exercise | $0 | +292 | +29% | $0.000000 | 1,294 | 18 Feb 2025 | Direct | |
| transaction | NOC | Common Stock | Tax liability | $44,136 | -100 | -7.7% | $441.36 | 1,194 | 18 Feb 2025 | Direct | |
| transaction | NOC | Common Stock | Sale | $130,488 | -293 | -25% | $445.35 | 901 | 18 Feb 2025 | Direct | F1 |
| holding | NOC | Common Stock | 0 | 18 Feb 2025 | Held in Northrop Grumman Savings Plan | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NOC | Restricted Performance Stock Rights | Award | $0 | +5,400 | +83% | $0.000000 | 11,925 | 18 Feb 2025 | Common Stock | 5,400 | Direct | F3, F4, F5 | |
| transaction | NOC | Restricted Stock Rights | Award | $0 | +2,456 | +86% | $0.000000 | 5,309 | 18 Feb 2025 | Common Stock | 2,456 | Direct | F6, F7, F8 | |
| transaction | NOC | Restricted Performance Stock Rights | Options Exercise | $0 | -685 | -5.7% | $0.000000 | 11,240 | 18 Feb 2025 | Common Stock | 685 | Direct | F3, F9 | |
| transaction | NOC | Restricted Stock Rights | Options Exercise | $0 | -292 | -5.5% | $0.000000 | 5,017 | 18 Feb 2025 | Common Stock | 292 | Direct | F6, F10 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2024. |
| F2 | Held in the Northrop Grumman Savings Plan (the "Plan"), a qualified defined contribution plan, as of February 18, 2025. Share totals with respect to the Plan are based upon unit accounting and therefore may reflect a change in units attributable to an individual though no acquisition or disposition occurred. |
| F3 | Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |
| F4 | The RPSRs acquired include (i) 44.80 vested RPSRs with respect to the measurement period ended 12/31/24 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/15/22 that resulted in settlement at 107% of the target award; and (ii) 5,355 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/18/25 with a measurement period ending on 12/31/27. A total of 684.80 shares were issued in settlement of the 2022 RPSRs with a measurement period that ended 12/31/24, and the target award amount of 640 RPSRs was previously reported in connection with the grant of the 2022 RPSRs. |
| F5 | Total amount includes (i) 684.80 vested RPSRs granted under the 2011 LTISP on 2/15/22 with a measurement period ended on 12/31/24; (ii) 639 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (iii) 1,495 RPSRs granted under the 2011 LTISP on 11/1/23 with a measurement period ending on 12/31/25; (iv) 2,352 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (v) 1,399 RPSRs granted under the 2024 LTISP on 7/31/24 with a measurement period ending 12/31/26; and (vi) 5,355 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27. |
| F6 | Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. |
| F7 | The RSRs were granted under the 2024 LTISP on 2/18/2025 and will vest on 2/18/2028. |
| F8 | Total amount includes (i) 292 RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25; (ii) 274 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (iii) 641 RSRs granted under the 2011 LTISP on 11/1/23 that will vest on 11/2/26; (iv) 1,008 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (v) 638 RSRs granted under the 2024 LTISP on 7/31/24 that will vest on 8/2/27; and (vi) 2,456 RSRs granted under the 2024 LTISP on 2/18/25 that will vest on 2/18/28. |
| F9 | Total amount includes (i) 639 RSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (ii) 1,495 RPSRs granted under the 2011 LTISP on 11/1/23 with a measurement period ending on 12/31/25; (iii) 2,352 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (iv) 1,399 RPSRs granted under the 2024 LTISP on 7/31/24 with a measurement period ending on 12/31/26; and (v) 5,355 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27. |
| F10 | Shares issued upon vesting of RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25. |